Navigation Links
Follow-ups prove powerful tool for treating depression in primary care
Date:10/26/2010

ANN ARBOR, Mich. In the 15 minutes a primary care doctor typically has with a patient, she's expected to diagnose the current ailment, help manage ongoing health issues and provide preventive care. In this setting, confronting all but the most obvious and immediate mental health needs of patients is an ongoing challenge.

A new study by researchers at the University of Michigan Health System, however, points to an encouraging strategy for improving and sustaining mental health results in chronically depressed patients by providing small amounts of flexible, targeted follow-up care without overburdening busy doctors' offices.

The study, published in the September/October issue of Annals of Family Medicine, shows that patients who received interventions that included self-monitoring tools and follow-up phone calls from a care manager were more likely a year and a half later to have symptoms that were in remission and to have fewer reduced-function days than those receiving usual primary care treatment.

"They key is to keep patients engaged in treatment," says Michael Klinkman, M.D., M.S., a professor of family medicine at the University of Michigan Medical School and lead author of the study. "What it's not is telephone therapy. Patients have a human contact, somebody who can help them become more actively involved in their own care. It's hard to do that if you're just spoon feeding information to 'educate' a patient or telling them to go to a website."

With a more traditional approach that depends on a follow-up office visit, it might be months before a primary care doctor learns that his patient's depression is getting worse. And in many cases patients simply don't follow up.

For the study, a care manager worked in collaboration with doctors' practices, rather than on the side or independently, Klinkman says. That helps the family practice office to act as a home base for all of a patient's medical needs. The approach can also serve as a model for treating other types of chronic conditions, he adds.

Many patients have depression alongside other mental health and medical problems, Klinkman notes.

"There are people with chronic issues who have had multiple depressive episodes in the past," he says. "No one wants to study them because it's hard to make them better. But we didn't cherry pick, we took everyone and the rate of remission we saw was about double what it has been with usual care. The other thing that is really noteworthy: the results persisted over time."

While some patients did become less engaged when their symptoms started getting better, many got back in touch with their care manager when things started to slip again.

"We helped get people back into care who otherwise might not have returned to treatment," Klinkman says.

Meanwhile, the U-M Depression Center has recently launched a new web-based toolkit for patients and their families, which is also intended to be a resource for primary care physicians.

The site, depressiontoolkit.org, has a wealth of resources and downloadable tools that can help individuals assess whether they might be suffering from depression, and tips for how to talk with others about depression. Several of the tools developed for the study were integrated into the Depression Center Toolkit.


'/>"/>

Contact: Ian Demsky
idemsky@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert

Related medicine news :

1. Falls and follow-ups: Medical attention following a fall critical to senior health
2. Radiation therapy improves painful condition associated with multiple sclerosis
3. Testing lifestyle changes to improve health for people with HIV infections
4. BUSM study shows patient navigations improve mammography rates in minority women
5. Virtual colonoscopy option could improve colorectal cancer screening rates, patient survey suggests
6. Pradaxa Approved to Fight Dangerous Irregular Heartbeat, Stroke
7. New Tumor Marker May Improve Cancer Detection: Study
8. Yoga alleviates pain and improves function in fibromyalgia patients
9. First Patient Treated in U.S.-Approved Embryonic Stem Cell Trial
10. Adding topotecan to standard treatment for ovarian cancer does not improve progression-free survival
11. Stanford-led study disproves link between genetic variant, risk of coronary artery disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... ... program owned and organized by HMP Communications Holdings, LLC, today announced that ... within its nationwide network of wound centers interested in becoming Certified Wound Specialist ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... solutions, today named The Resource Group as their 2016 Microsoft Dynamics Partner of ... in Newport Beach, CA. The award recognizes The Resource Group for their ...
(Date:3/23/2017)... Boca Raton, FL (PRWEB) , ... March 23, ... ... range of dietary supplements that help improve all aspects of people’s health and ... popular website for nutritional products. , Natural Subsistence develops nutritional supplements that ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... with all Americans facing life-altering and fatal diseases in opposition to the ... decisions that would eviscerate care, services, and hope for the most vulnerable among ...
(Date:3/23/2017)... Rey, CA (PRWEB) , ... March 23, 2017 ... ... its customizable coding audit software solution, iCode Assurance, at HCCA’s 21st annual Compliance ... optimizes and accelerates the coding audit process for all medical chart types with ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... Denmark , March 23, 2017 Ascendis ... its innovative TransCon technology to address significant unmet medical ... will host a conference call and webcast on Monday, ... the Endocrine Society in Orlando, Florida ... disease pipeline candidates (TransCon Growth Hormone, TransCon PTH and ...
(Date:3/23/2017)... 2017  Cornerstone Pharmaceuticals, Inc., a clinical-stage, ... today.  Following successful End-of-Phase I (EOP1) Type ... Drug Administration (FDA), the Company has been ... forward to conduct pivotal trials of its ... myeloid leukemia (AML) and pancreatic cancer. ...
(Date:3/23/2017)... AVIV, Israel , March 23, 2017 ... on oncology and immunology, announced today that it has acquired ... immunotherapy platform. Acquisition consideration consisted of a $6 million upfront ... remainder in BioLineRx shares. Additional future payments may be made ... ...
Breaking Medicine Technology: